Search research articles
Contact Us
Filters
Showing results (121-130 of 196) with videos related to
Page
of 20
Sort By:
Cancers
|
November 13, 2021
Seasonal Variations in the Diagnosis of Testicular Germ Cell Tumors: A National Cancer Registry Study in Austria
Gennadi Tulchiner, Nina Staudacher, Josef Fritz, et al.
Cancer Immunology, Immunotherapy : CII
|
February 1, 2025
Novel combination therapy for platinum-eligible patients with locally advanced or metastatic urothelial carcinoma: a systematic review and network meta-analysis
Takafumi Yanagisawa, Keiichiro Mori, Akihiro Matsukawa, et al.
Urologic Oncology
|
July 12, 2021
Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-up
Dominik A Barth, Nazanin Sareban, Andrea K Lindner, et al.
Minerva Urology and Nephrology
|
June 14, 2023
Stage-dependent survival in patients treated with neoadjuvant chemotherapy and radical cystectomy
David D'Andrea, Shahrokh F Shariat, Francesco Soria, et al.
Clinical and Translational Medicine
|
March 10, 2026
Multi-omic profiling defines three distinct molecular subtypes of urothelial carcinoma with implications for precision therapy
Nils C H van Creij, Piotr Tymoszuk, Florian Handle, et al.
Journal of Clinical Medicine
|
April 13, 2024
Treating BCG-Induced Cystitis with Combined Chondroitin and Hyaluronic Acid Instillations in Bladder Cancer
Renate Pichler, Johannes Stäblein, Andrea Mari, et al.
European Urology Oncology
|
July 27, 2025
FGFR1/3 Signaling as an Achilles' Heel of Phenotypic Diversity in Urothelial Carcinoma
Renate Pichler, Nils C H van Creij, Laura S Mertens, et al.
Clinical Genitourinary Cancer
|
December 13, 2023
Systemic Immune-Inflammation Index in Patients Treated With First-Line Immune Combinations for Metastatic Renal Cell Carcinoma: Insights From the ARON-1 Study
Fernando Sabino Marques Monteiro, Ondřej Fiala, Francesco Massari, et al.
The Oncologist
|
July 3, 2024
Cisplatin eligibility in the neoadjuvant setting of patients with muscle-invasive bladder cancer undergoing radical cystectomy
Renate Pichler, Josef Fritz, Andrea Mari, et al.
Clinical Genitourinary Cancer
|
November 7, 2024
Risk of Metachronous Upper Tract Urothelial Carcinoma After Ureteral Stenting in Patients With Bladder Cancer
Pietro Scilipoti, Marco Moschini, Mario de Angelis, et al.
Page
of 20
Search research articles
Search
Showing results (121-130 of 196) with videos related to
Sort By:
Page
of 20
Cancers
|
November 13, 2021
Seasonal Variations in the Diagnosis of Testicular Germ Cell Tumors: A National Cancer Registry Study in Austria
Gennadi Tulchiner, Nina Staudacher, Josef Fritz, et al.
Cancer Immunology, Immunotherapy : CII
|
February 1, 2025
Novel combination therapy for platinum-eligible patients with locally advanced or metastatic urothelial carcinoma: a systematic review and network meta-analysis
Takafumi Yanagisawa, Keiichiro Mori, Akihiro Matsukawa, et al.
Urologic Oncology
|
July 12, 2021
Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-up
Dominik A Barth, Nazanin Sareban, Andrea K Lindner, et al.
Minerva Urology and Nephrology
|
June 14, 2023
Stage-dependent survival in patients treated with neoadjuvant chemotherapy and radical cystectomy
David D'Andrea, Shahrokh F Shariat, Francesco Soria, et al.
Clinical and Translational Medicine
|
March 10, 2026
Multi-omic profiling defines three distinct molecular subtypes of urothelial carcinoma with implications for precision therapy
Nils C H van Creij, Piotr Tymoszuk, Florian Handle, et al.
Journal of Clinical Medicine
|
April 13, 2024
Treating BCG-Induced Cystitis with Combined Chondroitin and Hyaluronic Acid Instillations in Bladder Cancer
Renate Pichler, Johannes Stäblein, Andrea Mari, et al.
European Urology Oncology
|
July 27, 2025
FGFR1/3 Signaling as an Achilles' Heel of Phenotypic Diversity in Urothelial Carcinoma
Renate Pichler, Nils C H van Creij, Laura S Mertens, et al.
Clinical Genitourinary Cancer
|
December 13, 2023
Systemic Immune-Inflammation Index in Patients Treated With First-Line Immune Combinations for Metastatic Renal Cell Carcinoma: Insights From the ARON-1 Study
Fernando Sabino Marques Monteiro, Ondřej Fiala, Francesco Massari, et al.
The Oncologist
|
July 3, 2024
Cisplatin eligibility in the neoadjuvant setting of patients with muscle-invasive bladder cancer undergoing radical cystectomy
Renate Pichler, Josef Fritz, Andrea Mari, et al.
Clinical Genitourinary Cancer
|
November 7, 2024
Risk of Metachronous Upper Tract Urothelial Carcinoma After Ureteral Stenting in Patients With Bladder Cancer
Pietro Scilipoti, Marco Moschini, Mario de Angelis, et al.
Page
of 20